GCNT3 抗体 (N-Term)
GCNT3
适用: 人
IHC
宿主: 兔
Polyclonal
unconjugated
-
-
抗原
See all GCNT3 抗体
-
GCNT3
(Glucosaminyl (N-Acetyl) Transferase 3, Mucin Type (GCNT3))
-
抗原表位
-
N-Term
-
适用
-
人
-
宿主
-
兔
-
克隆类型
-
多克隆
-
标记
-
This GCNT3 antibody is un-conjugated
-
应用范围
-
Immunohistochemistry (IHC)
-
特异性
-
BLAST analysis of the peptide immunogen showed no homology with other human proteins, except NEK8 (60 % ).
-
纯化方法
-
Immunoaffinity Chromatography
-
免疫原
-
GCNT3 antibody was raised against a KLH conjugated synthetic peptide cooresponding to the N-Terminal domain of GCNT3.
-
Top Product
-
Discover our top product GCNT3 Primary Antibody
-
anti-Glucosaminyl (N-Acetyl) Transferase 3, Mucin Type (GCNT3) (C-Term) antibody
GCNT3
适用: 人, 小鼠, 大鼠, 犬, 马, Pig, 兔, Cow, Saccharomyces cerevisiae, 绵羊, 豚鼠
WB, IHC
宿主: 兔
Polyclonal
unconjugated
-
-
应用备注
-
GCNT3 antibody can be used in ELISA, Western Blot starting at 1:500 - 1:1000, immunohistochemistry starting at 5 μg/mL, and immunoprecipitation
-
限制
-
仅限研究用
-
-
状态
-
Liquid
-
缓冲液
-
PBS, 0.1 % sodium azide.
-
储存液
-
Sodium azide
-
注意事项
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
-
As with all antibodies avoid freeze/thaw cycles.
-
储存条件
-
4 °C/-80 °C
-
储存方法
-
GCNT3 antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.
-
-
抗原
-
GCNT3
(Glucosaminyl (N-Acetyl) Transferase 3, Mucin Type (GCNT3))
-
别名
-
GCNT3 (GCNT3 产品)
-
别名
-
C2/4GnT antibody, C24GNT antibody, C2GNT2 antibody, C2GNTM antibody, GNTM antibody, 2010013H22Rik antibody, 2210021I22Rik antibody, 2210401J11Rik antibody, beta-16-N-acetylglucosaminyltransferase antibody, dI/C2/C4GnT antibody, c2/4gnt antibody, c24gnt antibody, c2gnt2 antibody, c2gntm antibody, gntm antibody, glucosaminyl (N-acetyl) transferase 3, mucin type antibody, glucosaminyl (N-acetyl) transferase 3, mucin type L homeolog antibody, GCNT3 antibody, Gcnt3 antibody, gcnt3.L antibody
-
基因ID
-
9245
-
UniProt
-
O95395
-
途径
-
Production of Molecular Mediator of Immune Response
-